RxDoctor Payments Data
★ My doctorsLook up a doctor →

Aakriti Soni

Kingwood, TXNPI 1144892118

Payments from drug & device makers

$2,797in general payments, 2019–2025

Across 72 payments — averaging $38.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$504
  • E.r. Squibb & Sons, L.L.C.$458
  • Madrigal Pharmaceuticals$285
  • Regeneron Healthcare Solutions, Inc.$238
  • Axonics, Inc.$163
  • AstraZeneca$155
  • plus $994 from 17 others

What the payments were for

  • Food & beverage$2,797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie10$504
E.r. Squibb & Sons, L.L.C.21$458
Madrigal Pharmaceuticals2$285
Regeneron Healthcare Solutions, Inc.2$238
Axonics, Inc.1$163
AstraZeneca(2 entities)9$155
Johnson & Johnson1$140
Janssen Scientific Affairs, LLC1$126
Novo Nordisk1$120
Gilead2$116
Takeda Pharmaceuticals U.S.A., Inc.3$88
Grifols USA, LLC2$54
Boehringer Ingelheim3$50
Bayer2$40
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$39
UCB, Inc.1$36
Karyopharm Therapeutics Inc.2$32
Genentech USA, Inc.1$31
Lundbeck LLC1$30
Pfizer2$29
Sanofi1$29
Incyte Corporation1$18
Evoke Pharma, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →